Pathologic response and survival after cisplatin, pemetrexed, and bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer

被引：0
|
作者：
Tsutani, Y. [1 ]
Miyata, Y. [1 ]
Suzuki, K. [2 ]
Takamochi, K. [2 ]
Tanaka, F. [3 ]
Nakayama, H. [4 ]
Yamashita, Y. [5 ]
Oda, M. [6 ]
Tsuboi, M. [7 ]
Okada, M. [1 ]
机构：
[1] Hiroshima Univ, Surg Oncol, Hiroshima, Japan
[2] Juntendo Univ, Gen Thorac Surg, Sch Med, Tokyo, Japan
[3] Univ Occupat & Environm Hlth, Thorac Surg, Kitakyushu, Fukuoka, Japan
[4] Kanagawa Canc Ctr, Thorac Surg, Yokohama, Kanagawa, Japan
[5] Chugoku Canc Ctr, Kure Med Ctr, Thorac Surg, Kure, Japan
[6] Kanazawa Univ, Thorac Surg, Kanazawa, Ishikawa, Japan
[7] Natl Canc Ctr Hosp East, Thorac Surg & Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw382.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1197P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EFFICIENCY OF CISPLATIN, PEMETREXED, AND BEVACIZUMAB AS FIRST-LINE TREATMENT FOR JAPANESE ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS
    Shiraishi, Yoshimasa
    Hirai, Humihiko
    Yamaguchi, Masafumi
    Morodomi, Yosuke
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Takenaka, Tomoyoshi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [22] INDIRECT COMPARISON OF EFFICACY, SAFETY, AND COST: PEMETREXED/CISPLATIN VERSUS BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Orlando, Mauro
    Barraclough, Helen
    Orlov, Sergey
    Rajan, Narayan
    Davey, Peter
    Kanivets, Yana
    Han, Baoguang
    Brnabic, Alan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1232 - S1233
  • [23] Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer
    Takamochi, Kazuya
    Suzuki, Kenji
    Tsuboi, Masahiro
    Niho, Seiji
    Ishikura, Satoshi
    Oyamada, Shunsuke
    Yamaguchi, Takuhiro
    Okada, Morihito
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03): : 661 - +
  • [24] Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321
    Kasai, Takashi
    Mori, Kiyoshi
    Nakamura, Yoichi
    Seki, Nobuhiko
    Ichikawa, Yasuko
    Saito, Haruhiro
    Kondo, Tetsuro
    Nishikawa, Kazuo
    Otsu, Satoshi
    Bessho, Akihiro
    Tanaka, Hiroshi
    Yamaguchi, Hiroyuki
    Kaburagi, Takayuki
    Imai, Hisao
    Mori, Keita
    Ohtake, Junya
    Okamoto, Hiroaki
    CANCER MEDICINE, 2023, 12 (14): : 14988 - 14999
  • [25] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [26] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type
    Murakami, Shuji
    Saito, Haruhiro
    Kondo, Tetsuro
    Oshita, Fumihiro
    Yamada, Kouzo
    JOURNAL OF EXPERIMENTAL THERAPEUTICS AND ONCOLOGY, 2019, 13 (02) : 131 - 138
  • [28] Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study
    Santoro, Armando
    Hillerdal, Gunnar N.
    Hoeffkenc, Gert
    Favaretto, Adolfo
    Carrion, Ramon Perez
    Visseren-Grul, Carla
    Ameryckx, Sophie
    Helsberg, Karin
    Soldatenkova, Victoria
    Bourayou, Nawel
    Sorensen, Jens B.
    LUNG CANCER, 2014, 86 (01) : 47 - 53
  • [29] Review of the pemetrexed-cisplatin chemotherapy in non-squamous non-small cell lung cancer in Royal Shrewsbury Hospital
    Boon, C.
    Chatterjee, A.
    LUNG CANCER, 2013, 79 : S15 - S15
  • [30] Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer
    Tsuchiya, Tomoshi
    Matsumoto, Keitaro
    Miyazaki, Takuro
    Yamaguchi, Hiroyuki
    Yamazaki, Takuya
    Sano, Isao
    Fukuoka, Junya
    Nakamura, Yoichi
    Yamasaki, Naoya
    Nagayasu, Takeshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2019, 67 (06) : 537 - 543
12345